Dr David Woolf is a graduate of the University of Birmingham. His core medical and clinical oncology training was undertaken in London at University College Hospital, The Royal Free and St Bartholomew’s. Dr Woolf later completed a Masters in Oncology at the Institute of Cancer Research and a Doctorate of Medicine at Mount Vernon Cancer Centre.

He has a particular interest in the development of high-quality healthcare, participating as a member of the Keogh Quality of Care Review Inspections Panel and Clinical Expert in Care Quality Commission (CQC) inspections.

During his career, Dr Woolf has had over 20 publications in peer-reviewed journals, published book chapters, as well as over 40 oral and poster presentations to national and international conferences. These include multiple publications and presentations in the field of breast and lung cancer.

He also runs regular teaching sessions for junior doctors and examines on The Christie FRCR examination course. Dr Woolf has worked extensively with The Royal College of Radiologists to enhance training for clinical oncologists.

Dr Woolf plans and delivers radiotherapy at The Christie to patients with breast and lung cancers and also gives Stereotactic Ablative Radiotherapy (SABR) for lung cancers and oligometastases (cancers that have spread to the lungs). In addition, he gives hormone therapy (endocrine therapy), chemotherapy and targeted drugs.

• Breast cancer treatments
• Lung cancer treatments
• Radiotherapy
• Chemotherapy
• Hormone therapy (endocrine therapy)
• Targeted therapy
• Stereotactic Ablative Radiotherapy (SABR)
• Intraoperative Radiotherapy (IORT)

• General Medical Council
• Royal College of Radiologists
• Medical Protection Society
• American Society for Radiation Oncology
• European Society for Radiotherapy & Oncology
• American Society of Clinical Oncology
• European Society for Medical Oncology
• British Medical Association
• Faculty of Medical Leadership and Management